Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
(applications tested for the base form of this product only)
Specificity and Use
AKT3 antibody was raised against kLH-conjugated synthetic phosphopeptide around Ser472 of human AKT3.
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
PBS, pH 7.2.
May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for at least 12 months at 4°C. Freezing will result in loss of activity. PE conjugates are sensitive to light.
AKT3 Antibody, AKT3/PKBgamma Antibody, PRKBG Antibody, PKB gamma Antibody, Protein kinase Akt-3 Antibody, RAC-gamma Antibody, MPPH Antibody, PKB-GAMMA Antibody, PKBG Antibody, Protein kinase B gamma Antibody, RAC-PK-gamma Antibody, STK-2 Antibody
AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform.